Jefferies lifts target for Pro Medicus stock to AUD 199.00

Published on 10/24/2026 at 18:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Morgans sets a Buy rating and AUD 230.00 target. Pro Medicus stock last traded at AUD 198.38 on October 23, 2026, up 2.56 percent on ASX.

Analyst targets and results

Jefferies raised its Pro Medicus target to AUD 199.00 from AUD 198.30 on October 22, 2026.
Morgans upgraded Pro Medicus to Buy and kept its AUD 230.00 target on October 21, 2026.
Fiscal year 2026 revenue reached AUD 261.70 million, up 23.00 percent from fiscal year 2025.
Pro Medicus last traded at AUD 198.38 on October 23, 2026, up 2.56 percent from AUD 193.42.

Pro Medicus, AU000000PME8, Illustration mit AI erstellt.

Pro Medicus (ISIN AU000000PME8) received a higher Jefferies target of AUD 199.00 from AUD 198.30 on October 22, 2026, according to IBTimes Australia. On the ASX, Pro Medicus last traded at AUD 198.38 on October 23, 2026 at 4:10 p.m. AEDT, up 2.56 percent from AUD 193.42.

Analyst targets split by AUD 31.00

Jefferies kept a Hold rating while lifting its target by AUD 0.70. The same IBTimes Australia report said Morgans upgraded Pro Medicus from Accumulate to Buy and retained an AUD 230.00 target. The two targets differ by AUD 31.00, leaving investors with a wide range of broker assumptions.

What does the target imply for valuation?

The AUD 230.00 Morgans target stands 15.94 percent above the ASX price of AUD 198.38, while the Jefferies target is 0.31 percent higher. The current price-to-earnings ratio is 78.10 and the market capitalization is AUD 20.7 billion as of October 23, 2026.

Fiscal year 2026 growth remains measurable

Pro Medicus reported fiscal year 2026 revenue of AUD 261.70 million, up 23.00 percent from fiscal year 2025, while earnings per share reached AUD 2.54 versus AUD 1.10 in fiscal year 2025, according to Simply Wall St. The figures show that the valuation debate rests alongside a large reported earnings base rather than revenue growth alone.

November 25 sets the next date

Pro Medicus has scheduled its annual general meeting for November 25, 2026, in Melbourne and online, according to TipRanks. The company describes Visage 7, radiology workflow tools and cloud imaging software as its core products on its investor page.

ASX range leaves room for debate

The 52-week ASX range is AUD 107.75 to AUD 286.76, with 395,198 shares traded on October 23, 2026. The market capitalization and price-to-earnings ratio place the stock firmly in a valuation discussion, while the two recent broker targets point to different views of future execution.

Targets leave different margins

For the next market session, the key contrast is between Jefferies' near-market target of AUD 199.00 and Morgans' AUD 230.00 objective. Both figures are dated October 22, 2026 or October 21, 2026, and neither replaces the ASX price of October 23, 2026.